BioNTech co-founder 'confident' vaccine works against Indian variant

2021-04-28 1

BioNTech co-founder Ugur Sahin voices confidence that the vaccine his company jointly developed with Pfizer works against the Indian variant of the coronavirus. of Uğur Şahin

Videos similaires

FDA, tiniyak na mabisa ang COVID-19 vaccines vs. bagong variants; efficacy ng ilan pang COVID-19 vaccines vs. Delta variant, patuloy na pinag-aaralan

Philippe Doucet : «L'écart entre les vaccinés et les non-vaccinés concernant le variant Delta est de 1 à 12»

Express Balita: PHL, inihalal bilang chairperson ng gov't group ng int'l labor organization; Importansya ng info drive hinggil sa COVID-19 vaccines, binigyang-diin; Theta variant, 'di na maituturing na ‘variant of interest’ dahil sa pagbaba ng bilang ng n

Pagbahing at runny nose o sipon, posibleng sintomas ng COVID-19 Delta variant base sa ilang pag-aaral; Kumpletong doses ng COVID-19 vaccines, nananatiling epektibo vs. COVID-19 variants

OCTA Research Group, iginiit na mahalagang higpitan ang border control vs. COVID-19 variants; bibilhing 40-M doses ng Pfizer vaccines, makatutulong para mapabilis ang vaccine rollout

Double mutant Covid variant: Will existing vaccines work on new variants?

ICMR On Vaccine-Escaping Omicron Variant Cases: Vaccines Are Disease Modifying Not Preventive

Vaccine manufactures indicate existing vaccines may be ineffective against Omicron variant

Public health England: COVID-19 vaccines ng Pfizer at AstraZeneca, epektibo vs. Indian variant; Israel, tatapusin na ang pagpapatupad ng COVID-19 restrictions matapos ideklara na matagumpay ang vaccine rollout; British Prime Minister Boris Johnson, inan

EUA ng Pfizer, kailangan munang amyendahan bago magamit sa edad 12-15 sa Pilipinas; Vaccine Expert Panel, pinag-aaralan kung epektibo ang first generation vaccines vs. B.1.617 COVID-19 variant

Web Analytics